Mannheim, Germany

Ines Sauer

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Roche Palo Alto LLC. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ines Sauer. Retrieved from https://idiyas.com/inventor/ines-sauer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ines Sauer: Pioneering Innovation in Viral Inhibition

Introduction

Ines Sauer, an esteemed inventor based in Mannheim, Germany, has made significant contributions to the field of pharmaceutical sciences. She is recognized for her innovative work in the development of polymorphic forms of oseltamivir phosphate, a potent antiviral agent.

Latest Patents

Ines holds a patent for her invention titled "Polymorphic forms of oseltamivir phosphate." The patent details her work on polymorphic forms of (3R,4R,5S)-5-amino-4-acetylamino-3-(1-ethyl-propoxy)-cyclohex-1-ene-carboxylic acid ethyl ester phosphate, which effectively inhibits viral neuraminidase, making it a critical component in combating viral infections.

Career Highlights

Ines Sauer currently works at Roche Palo Alto LLC, where she continues to drive innovation in antiviral research. Her expertise and dedication have not only advanced her career but also contributed significantly to public health.

Collaborations

In her journey, Ines has collaborated with notable colleagues, including Pierre Goldbach and Olaf Grassmann. These collaborations have fostered a dynamic work environment that promotes innovative solutions in the pharmaceutical industry.

Conclusion

Through her inventive spirit and commitment to research, Ines Sauer exemplifies the role of a leading inventor in the field of pharmaceuticals. Her contributions are paving the way for advancements in the treatment of viral infections, demonstrating the profound impact that dedicated inventors can have on global health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…